Axsome Therapeutics (AXSM) Share-based Compensation Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | 0.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.56% |
| Dec 31, 2025 | 3.38% |
| Sep 30, 2025 | 6.66% |
| Jun 30, 2025 | 15.10% |
| Mar 31, 2025 | 15.44% |
| Dec 31, 2024 | 16.24% |
| Sep 30, 2024 | 32.33% |
| Jun 30, 2024 | 34.29% |
| Mar 31, 2024 | 55.99% |
| Dec 31, 2023 | -49.83% |
| Sep 30, 2023 | 177,871.08% |
| Jun 30, 2023 | 156,581.76% |
| Mar 31, 2023 | 170,247.46% |
| Dec 31, 2022 | 540.00% |
| Sep 30, 2022 | -99.84% |
| Jun 30, 2022 | -99.81% |
| Mar 31, 2022 | -99.80% |
| Dec 31, 2021 | 5.08% |
| Sep 30, 2021 | 99.57% |
| Jun 30, 2021 | 319.71% |
| Mar 31, 2021 | 74.88% |
| Dec 31, 2020 | 99.22% |
| Sep 30, 2020 | 148.07% |
| Jun 30, 2020 | 46.30% |
| Mar 31, 2020 | 69.83% |
| Dec 31, 2019 | 696.95% |
| Sep 30, 2019 | 194.51% |
| Jun 30, 2019 | 87.20% |
| Mar 31, 2019 | 135.01% |
| Dec 31, 2018 | -34.24% |
| Sep 30, 2018 | 1.19% |
| Jun 30, 2018 | -1.86% |
| Mar 31, 2018 | -19.45% |
| Dec 31, 2017 | 23.51% |
| Sep 30, 2017 | -15.36% |
| Jun 30, 2017 | 0.33% |
| Mar 31, 2017 | 1.13% |
| Dec 31, 2016 | 138.39% |
| Sep 30, 2016 | 27.09% |
| Jun 30, 2016 | 159.98% |
| Mar 31, 2016 | 777.73% |